Bristol Myers Squibb’s Zeposia (ozanimod) Receives CHMP’s Positive Opinion for Adult Patients with Moderately to Severely Active Ulcerative Colitis Published: 15 Oct, 2021 | Tags: Bristol Myers Squibb, Zeposia, ozanimod, […]readmore
Tags : BioNova
Shots: Sutro to receive $4M as licensing option fee, ~$200M as an option exercise fee, development, regulatory & commercial milestones along with royalties based on sales of STRO-001 in Greater […]readmore